Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease

MacDonald, Elizabeth A.; Frey, Gary; Namchuk, Mark N.; Harrison, Stephen C.; Hinshaw, Stephen M.; Windsor, Ian W.

doi:10.1021/acsinfecdis.1c00237

Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease

Journal Article · 01 August 2021 · ACS Infect. Dis.

DOI:https://doi.org/10.1021/acsinfecdis.1c00237· OSTI ID:1821717

MacDonald, Elizabeth A.; Frey, Gary; Namchuk, Mark N.; Harrison, Stephen C.; Hinshaw, Stephen M.; Windsor, Ian W.

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; National Institutes of Health (NIH)

OSTI ID:: 1821717

Journal Information:: ACS Infect. Dis., Vol. 7, Issue (9)

Country of Publication:: United States

Language:: ENGLISH

References (26)

Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs No authors listed Science https://doi.org/10.1126/science.1085658		June 2003
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design No authors listed FEBS Journal https://doi.org/10.1111/febs.12936		August 2014
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors No authors listed Science https://doi.org/10.1126/science.abb3405		March 2020
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188 No authors listed Viruses https://doi.org/10.3390/v13020174		January 2021
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease No authors listed Cell Research https://doi.org/10.1038/s41422-020-0356-z		June 2020
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice No authors listed Science Translational Medicine https://doi.org/10.1126/scitranslmed.abc5332		August 2020
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease No authors listed Science https://doi.org/10.1126/science.abb4489		April 2020
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site No authors listed Nature Communications https://doi.org/10.1038/s41467-020-19662-4		November 2020
Conservation of substrate specificities among coronavirus main proteases No authors listed Journal of General Virology https://doi.org/10.1099/0022-1317-83-3-595		March 2002
Processing of Open Reading Frame 1a Replicase Proteins nsp7 to nsp10 in Murine Hepatitis Virus Strain A59 Replication No authors listed Journal of Virology https://doi.org/10.1128/JVI.00017-07		October 2007
Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis No authors listed Cell https://doi.org/10.1016/j.cell.2020.11.016		January 2021
Coronavirus replication–transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit No authors listed Proceedings of the National Academy of Sciences https://doi.org/10.1073/pnas.2022310118		January 2021
Processing of the SARS-CoV pp1a/ab nsp7–10 region No authors listed Biochemical Journal https://doi.org/10.1042/BCJ20200029		March 2020
Subtilisin. Stereochemical mechanism involving transition-state stabilization No authors listed Biochemistry https://doi.org/10.1021/bi00773a016		November 1972
Enzyme Catalysis by Hydrogen Bonds: The Balance between Transition State Binding and Substrate Binding in Oxyanion Holes No authors listed The Journal of Organic Chemistry https://doi.org/10.1021/jo901503d		March 2010
Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design No authors listed Journal of Virology https://doi.org/10.1128/JVI.02114-07		December 2007
Structural basis for the dimerization and substrate recognition specificity of porcine epidemic diarrhea virus 3C-like protease No authors listed Virology https://doi.org/10.1016/j.virol.2016.04.018		July 2016
N‐Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS‐CoV‐2 Main Protease No authors listed PROTEOMICS https://doi.org/10.1002/pmic.202000246		November 2020
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging No authors listed Nature Chemical Biology https://doi.org/10.1038/s41589-020-00689-z		October 2020
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity No authors listed Proceedings of the National Academy of Sciences https://doi.org/10.1073/pnas.1601327113		October 2016
Production of Authentic SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage Endopeptidase for Protein Overproduction No authors listed Journal of Molecular Biology https://doi.org/10.1016/j.jmb.2006.11.073		February 2007
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography No authors listed Nature Communications https://doi.org/10.1038/s41467-020-16954-7		June 2020
Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle No authors listed Biochemical Journal https://doi.org/10.1042/BCJ20200223		April 2020
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates No authors listed Bioorganic & Medicinal Chemistry Letters https://doi.org/10.1016/j.bmcl.2010.08.022		October 2010
Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1′-P2′ ligands No authors listed Bioorganic & Medicinal Chemistry Letters https://doi.org/10.1016/j.bmcl.2017.09.003		November 2017
Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors No authors listed Bioorganic & Medicinal Chemistry Letters https://doi.org/10.1016/j.bmcl.2018.01.064		March 2018

Similar Records

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Journal Article · 2020 · Cell Res. · OSTI ID:1671112

Ma, Chunlong; Sacco, Michael Dominic; Hurst, Brett; +8 more

Probing the SARS-CoV-2 main protease active site as a target to inhibit viral replication

Journal Article · 2021 · Research Features · OSTI ID:1770639

Kneller, Daniel; Coates, Leighton; Kovalevskyi, Andrii Y.

Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance

Journal Article · 2023 · Nature Communications · OSTI ID:1875652

Shaqra, A; Zvornicanin, S.; Huang, Q.; +10 more

Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease

Citation Formats

References (26)

Similar Records

Related Subjects